In this Friday’s PCT Grand Rounds, Dr. Adam DeVore of Duke University and Dr. Lars Lund of the Karolinska Institutet will present “SPIRRIT-HFpEF: Opportunities and Challenges in a Large Registry-Based Randomized Clinical Trial.” The Grand Rounds session will be held on Friday, February 4, at 1:00 pm eastern.
SPIRRIT-HFpEF is using a registry-based randomized clinical trial design to determine whether initiation of spironolactone plus usual care improves outcomes of patients with heart failure with preserved ejection fraction compared with usual care alone.